Zhu YZ - Search Results

1

Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancer.

Chen X, Hu ZP, Yang XX, Huang M, Gao Y, Tang W, Chan SY, Dai X, Ye J, Ho PC, Duan W, Yang HY, Zhu YZ, Zhou SF. Chen X, et al. Among authors: zhu yz. Int Immunopharmacol. 2006 Mar;6(3):499-508. doi: 10.1016/j.intimp.2005.08.026. Epub 2005 Sep 15. Int Immunopharmacol. 2006. PMID: 16428086 Clinical Trial.

2

St. John's Wort modulates the toxicities and pharmacokinetics of CPT-11 (irinotecan) in rats.

Hu Z, Yang X, Ho PC, Chan E, Chan SY, Xu C, Li X, Zhu YZ, Duan W, Chen X, Huang M, Yang H, Zhou S. Hu Z, et al. Among authors: zhu yz. Pharm Res. 2005 Jun;22(6):902-14. doi: 10.1007/s11095-005-4585-0. Epub 2005 Jun 8. Pharm Res. 2005. PMID: 15948034

3

Topotecan is a substrate for multidrug resistance associated protein 4.

Tian Q, Zhang J, Chan SY, Tan TM, Duan W, Huang M, Zhu YZ, Chan E, Yu Q, Nie YQ, Ho PC, Li Q, Ng KY, Yang HY, Wei H, Bian JS, Zhou SF. Tian Q, et al. Among authors: zhu yz. Curr Drug Metab. 2006 Jan;7(1):105-18. doi: 10.2174/138920006774832550. Curr Drug Metab. 2006. PMID: 16454695

4

A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-alpha inhibitor.

Yang XX, Hu ZP, Xu AL, Duan W, Zhu YZ, Huang M, Sheu FS, Zhang Q, Bian JS, Chan E, Li X, Wang JC, Zhou SF. Yang XX, et al. Among authors: zhu yz. J Pharmacol Exp Ther. 2006 Oct;319(1):82-104. doi: 10.1124/jpet.106.103606. Epub 2006 Jun 30. J Pharmacol Exp Ther. 2006. PMID: 16815871

5

St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis.

Hu ZP, Yang XX, Chan SY, Xu AL, Duan W, Zhu YZ, Sheu FS, Boelsterli UA, Chan E, Zhang Q, Wang JC, Ee PL, Koh HL, Huang M, Zhou SF. Hu ZP, et al. Among authors: zhu yz. Toxicol Appl Pharmacol. 2006 Oct 15;216(2):225-37. doi: 10.1016/j.taap.2006.05.020. Epub 2006 Jul 21. Toxicol Appl Pharmacol. 2006. PMID: 17015070

6

Drug-herb interactions: eliminating toxicity with hard drug design.

Yang XX, Hu ZP, Duan W, Zhu YZ, Zhou SF. Yang XX, et al. Among authors: zhu yz. Curr Pharm Des. 2006;12(35):4649-64. doi: 10.2174/138161206779010440. Curr Pharm Des. 2006. PMID: 17168768 Review.

7

Human multidrug resistance associated protein 4 confers resistance to camptothecins.

Tian Q, Zhang J, Tan TM, Chan E, Duan W, Chan SY, Boelsterli UA, Ho PC, Yang H, Bian JS, Huang M, Zhu YZ, Xiong W, Li X, Zhou S. Tian Q, et al. Among authors: zhu yz. Pharm Res. 2005 Nov;22(11):1837-53. doi: 10.1007/s11095-005-7595-z. Pharm Res. 2005. PMID: 16132345

8

Metabolism and transport of oxazaphosphorines and the clinical implications.

Zhang J, Tian Q, Yung Chan S, Chuen Li S, Zhou S, Duan W, Zhu YZ. Zhang J, et al. Among authors: zhu yz. Drug Metab Rev. 2005;37(4):611-703. doi: 10.1080/03602530500364023. Drug Metab Rev. 2005. PMID: 16393888 Review.

9

An Update on AMPK in Hydrogen Sulfide Pharmacology.

Wang M, Tang W, Zhu YZ. Wang M, et al. Among authors: zhu yz. Front Pharmacol. 2017 Nov 8;8:810. doi: 10.3389/fphar.2017.00810. eCollection 2017. Front Pharmacol. 2017. PMID: 29167642 Free PMC article. Review.

10

S-Propargyl-Cysteine, a Novel Hydrogen Sulfide Donor, Inhibits Inflammatory Hepcidin and Relieves Anemia of Inflammation by Inhibiting IL-6/STAT3 Pathway.

Wang M, Tang W, Xin H, Zhu YZ. Wang M, et al. Among authors: zhu yz. PLoS One. 2016 Sep 20;11(9):e0163289. doi: 10.1371/journal.pone.0163289. eCollection 2016. PLoS One. 2016. PMID: 27649298 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

515 results

Search Page